%0 Journal Article
%T PI3K-AKT-mTOR pathway alterations in advanced NSCLC patients after progression on EGFR-TKI and clinical response to EGFR-TKI plus everolimus combination therapy
%A Fang, Wenfeng
%A Huang, Yihua
%A Gu, Weiguang
%A Gan, Jiadi
%A Wang, Wenjing
%A Zhang, Shiyue
%A Wang, Kai
%A Zhan, Jianhua
%A Yang, Yunpeng
%A Huang, Yan
%A Zhao, Hongyun
%A Zhang, Li
%J Translational Lung Cancer Research
%D 2020
%B 2020
%9 
%! PI3K-AKT-mTOR pathway alterations in advanced NSCLC patients after progression on EGFR-TKI and clinical response to EGFR-TKI plus everolimus combination therapy
%K 
%X 
%U https://tlcr.amegroups.org/article/view/42164
%V 9
%N 4
%P 1258-1267
%@ 2226-4477